POT1 loss-of-function variants predispose to familial melanoma
about
Disruption of Wnt/β-Catenin Signaling and Telomeric Shortening Are Inextricable Consequences of Tankyrase Inhibition in Human CellsUpdate in genetic susceptibility in melanomaOncogenomic portals for the visualization and analysis of genome-wide cancer dataCross-species models of human melanomaMultiple Molecular Pathways in Melanomagenesis: Characterization of Therapeutic TargetsThe short and long telomere syndromes: paired paradigms for molecular medicinePharmacogenetics and pharmacogenomics as tools in cancer therapyTelomere maintenance and the etiology of adult gliomaGermline mutations in shelterin complex genes are associated with familial gliomaFocused Analysis of Exome Sequencing Data for Rare Germline Mutations in Familial and Sporadic Lung CancerStructural and functional analysis of the human POT1-TPP1 telomeric complex.Structural insights into POT1-TPP1 interaction and POT1 C-terminal mutations in human cancerSynthetic lethality: emerging targets and opportunities in melanoma.Genomic analysis and clinical management of adolescent cutaneous melanoma.Genetic profiling of a rare condition: co-occurrence of albinism and multiple primary melanoma in a Caucasian family.Rare missense variants in POT1 predispose to familial cutaneous malignant melanomaMelanoma genetics.The telomeric protein Pot1 from Schizosaccharomyces pombe binds ssDNA in two modes with differing 3' end availability.The effect on melanoma risk of genes previously associated with telomere length.Genetics of familial melanoma: 20 years after CDKN2A.Telomere-regulating genes and the telomere interactome in familial cancers.Telomere length and recurrence risk after curative resection in patients with early-stage non-small-cell lung cancer: a prospective cohort study.Nonsense mutations in the shelterin complex genes ACD and TERF2IP in familial melanomaDefective repair of uracil causes telomere defects in mouse hematopoietic cells.DCAF4, a novel gene associated with leucocyte telomere length.Molecular characterization of melanoma cases in Denmark suspected of genetic predispositionQuantitative Fitness Analysis Identifies exo1∆ and Other Suppressors or Enhancers of Telomere Defects in Schizosaccharomyces pombe.A primary melanoma and its asynchronous metastasis highlight the role of BRAF, CDKN2A, and TERTAssociation between TERT promoter polymorphisms and acute myeloid leukemia risk and prognosis.Dissecting Fission Yeast Shelterin Interactions via MICro-MS Links Disruption of Shelterin Bridge to TumorigenesisExome sequencing of lymphomas from three dog breeds reveals somatic mutation patterns reflecting genetic backgroundA mutation in the POT1 gene is responsible for cardiac angiosarcoma in TP53-negative Li-Fraumeni-like families.Germline TERT promoter mutations are rare in familial melanoma.High nevus counts confer a favorable prognosis in melanoma patients.Recent developments in brain tumor predisposing syndromes.Therapeutic inhibition of TRF1 impairs the growth of p53-deficient K-RasG12V-induced lung cancer by induction of telomeric DNA damageSystematic Functional Interrogation of Rare Cancer Variants Identifies Oncogenic AllelesGenome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma.Telomere Replication Stress Induced by POT1 Inactivation Accelerates Tumorigenesis.Integrated pathway and epistasis analysis reveals interactive effect of genetic variants at TERF1 and AFAP1L2 loci on melanoma risk.
P2860
Q24337325-6B2106B2-FFFB-4B00-BA0C-16CA73B30F26Q26778756-19ED53FA-B196-4251-A371-3889E5B216CBQ26781295-2BD3E2BA-2053-462D-9CAB-B7B46FB4131EQ26782090-BCFB07EC-517C-4024-9353-2E0992ED72C4Q26795735-930D3C13-EDCC-4039-845F-7E08A67E2D4FQ26800388-A15DF249-C709-4524-A520-6A280487709CQ28076200-ABAF6B5C-64FF-4D23-8AB5-951040B6F586Q28084275-55D353DE-4FF3-41F1-93CC-DEC61374CAD9Q28253456-99D26EC8-2780-4C42-AF54-62A39F2F49FFQ31036731-477858FA-ADD5-45B6-A2CE-B5BDF317CA50Q33571860-9CE6E47A-8C6D-4268-96BF-182E591CEF6AQ33571895-0A671BCB-0DBB-4323-A0D5-CA24A9225D31Q33578398-4E4A372E-E49D-4127-8C28-9BB63ED987F9Q33701435-B4237213-3931-486A-BE9C-7BFA7E032AD2Q33728131-761D4A03-2A25-4E5E-A480-05B88A79DA46Q33751971-AA7E5989-F904-4D5C-B5D0-2CEF37127CE9Q34044830-F8F93870-2838-4DA6-8153-DFA198A1EC1DQ34115464-DEDD318B-5E5F-42D8-B811-4779CF785069Q34333988-BFF76F7A-E764-45B9-8266-6555DD3A1A43Q34449957-EBC7359D-9199-433F-A86B-CA722DE04943Q34784471-E66B8FA6-1308-4329-B9A9-1192228B815CQ35007976-E3157059-CA4D-4063-A201-1C4BACD17BEAQ35102528-12177451-98C4-4980-968F-07DE354888A2Q35126631-587A9338-9FCE-4E1A-B143-30C7F4BEB106Q35135855-4B6BFA4F-1686-4727-AFF0-1193A38ADBC7Q35213835-40A238D4-3983-4C51-A687-94762AA565C5Q35689663-3CB3D116-9342-4FED-83CA-AA6FDABB7B3BQ35751775-BD4D8FD5-91B3-42CA-AEBD-6C9F291033E3Q35753087-16AD0BC1-93FF-49D3-BD61-AD95AF501DBEQ35771953-535FDF67-F56E-4040-8E8F-E6268693E5D3Q35777971-5AD5B8B5-9EBE-4B56-B7A5-78FC15A9E467Q35786931-3715BB0A-2B3D-4B16-AC1B-679701243E9CQ35798435-14532AFF-2314-496B-B2DC-CB76C30D5E65Q35855182-CC8BDC69-6A9E-4FC3-A3DD-8581C7F6092CQ35860402-CFC4A876-F492-4B80-9283-FE1689A1AB40Q35904248-67207F81-AF60-4E9E-A7A0-939F88D0B049Q36009016-6A22DC9C-E719-4CDC-B833-3F5231C9F39AQ36019187-7688AB0D-6B07-4577-B9EA-D27841FB5D6AQ36033609-EC86E057-74E2-4F44-9AC0-CB5969452BDBQ36051433-8518E03F-9B72-4710-85C7-5221B967556E
P2860
POT1 loss-of-function variants predispose to familial melanoma
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
POT1 loss-of-function variants predispose to familial melanoma
@ast
POT1 loss-of-function variants predispose to familial melanoma
@en
POT1 loss-of-function variants predispose to familial melanoma
@en-gb
POT1 loss-of-function variants predispose to familial melanoma
@nl
type
label
POT1 loss-of-function variants predispose to familial melanoma
@ast
POT1 loss-of-function variants predispose to familial melanoma
@en
POT1 loss-of-function variants predispose to familial melanoma
@en-gb
POT1 loss-of-function variants predispose to familial melanoma
@nl
prefLabel
POT1 loss-of-function variants predispose to familial melanoma
@ast
POT1 loss-of-function variants predispose to familial melanoma
@en
POT1 loss-of-function variants predispose to familial melanoma
@en-gb
POT1 loss-of-function variants predispose to familial melanoma
@nl
P2093
P2860
P50
P3181
P356
P1433
P1476
POT1 loss-of-function variants predispose to familial melanoma
@en
P2093
Andrew J Ramsay
David J Adams
Helen Snowden
Jane M Palmer
Jessamy C Tiffen
Jimmy Z Liu
Jiyeon Choi
Judith Symmons
Karen A Pooley
Kevin M Brown
P2860
P2888
P304
P3181
P356
10.1038/NG.2947
P407
P50
P577
2014-03-30T00:00:00Z
P6179
1011869724